Format for Application for Research Projects under

Grant-in-Aid Scheme and Guidelines for Operation of Projects

Department of Health Research

Ministry of Health and Family Welfare,
Government of India
V. Ramalingaswami Bhawan, Ansari Nagar, Post Box No. 4911
New Delhi 110029

Tel. :

26588895, 26588980,
26589794, 26589336
Email: headquarters@icmr.org.in
icmrhqds@sansad.nic.in

GRAM
FAX

: SCIENTIFIC
: 011-26588662

Department of Health Research

V. Ramalingawami Bhawan, Ansari Nagar, Post Box No. 4911
New Delhi - 110029
APPLICATION FOR RESEARCH PROJECT UNDER GRANT-IN-AID SCHEME
(Please furnish 10 copies alongwith a CD and the font size of the content should be at least 11 pt, else the
proposal will not be evaluated)

Section A
GENERAL
1. Title of the Research Project
2. Tick the relevant component of the scheme as identified earlier in concept research proposal

i.
ii.
iii.
iv.

Research studies with emphasis on public health

Translational Research Projects
Inter-sectoral co-ordination including funding of joint projects
Cost-effectiveness analysis of health technologies through a health technology
assessment system
3. State the major discipline (for details see Annexure 1):
4. Name and Designation of
i)
ii)

Principal Investigator & Email

Co-Investigator(s) & Email

5. Duration of Research Project

i) Period which may be needed for collecting the data
ii) Period that may be required for analyzing the data
6. Amount of grant-in-aid asked for (details are to be furnished in Section B)
SN

Item- Head

1.

Staff

2.

Contingencies

3.

Recurring

4.

Non recurring
(equipment )

5.

Travel

6.

Overhead
Charges

1st Year
(in Rs)

2nd Year
(in Rs)

Total

7. Institution responsible for the research project

3rd Year
(in Rs)

Total
(in Rs.)

i.
ii.
iii.

Name
Postal address
Telephone

e- mail
v.
Fax No.
8. In case of Inter-sectoral research projects
i.
Name(s) of the Institution (s) / Agencies
ii.
Whether contributed financially
iii.
Amount / Budget contributed for this project
iv.

9. Institutional ethical clearance and Project approval (Necessary documents indicating

institutional ethical clearance must be enclosed for research involving human subjects as also
animal experiments).
Yes
No
10. Is radio tagged material proposed to be used in the project either for clinical trials or
experimental purposes? If so, clearance from Nuclear Medicine Committee, Bhabha
Atomic Research Centre, Mumbai, indicating should be attached.
11. Projects involving recombinant DNA/Genetic engineering work should be examined and
certificate by the Institutional Biosafety Committee (IBSC) to be enclosed. Guidelines for
constitution of IBSC can be obtained from Secretary, Department of Biotechnology, CGO
Complex, Lodhi Road, New Delhi-110003.
12. Approval of the institutional ethics committee(IEC) should be enclosed. Guidelines for IEC
for animal experiments should follow CPCSEA requirements and for human studies
should follow ICMR guidelines.
13. The Institution where the study is being done should ensure that there is no financial
conflict of interest by the investigators.
14. Whether your institution (private / NGO) is registered with Department of Scientific and
Industrial Research (DSIR), Government of India/ Department of Health Research (DHR) as a
health research institute. If yes, certificate from DSIR/ DHR should be attached.
DECLARATION AND ATTESTATION
i.

ii.

iii.
iv.

I/We have read the terms and conditions for DHR Research Grant. All necessary
Institutional facilities will be provided if the research project is approved for financial
assistance.
I/We agree to submit within one month from the date of termination of the project the
final report and a list of articles, both expendable and non-expendable, left on the closure
of the project.
I/We agree to submit audited statement of accounts duly audited by the auditors as
stipulated by the DHR.
It is certified that
the equipment(s) is/ are not available in the Institute /
Department or these are available but cannot be spared for the project

It is further certified that the equipment(s) required for the project have not been purchased
from the funds provided by DHR for another project(s) in the Institute.
v.
I/We agree to submit (online) all the raw data (along with descriptions) generated from the
project to the DHR / ICMR Data Repository within one month from the date of completion
/termination of the project.
If any equipment already exists with the Department/Institute, the investigator
should justify purchase of the another equipment.

iv.

Signature of the:
a) Principal Investigator
b) Co-Investigator(s)
c) Head of the Department
Signature of the Head of the Institution with
seal
Date:

P.S. DHR should be reminded if no acknowledgement is received within one month from
the date of sending the application.

Section - B
DETAILS OF THE RESEARCH PROJECT
Adequate information must be furnished in a brief but self-contained manner to enable
the Council to assess the project.
1. Title of the project.
2. Objectives
5. Summary of the proposed research (up to 150 words) indicating overall aims of the

research and importance of the research proposal. Application of the work in the
context of national priorities of medical research, if any, may also be mentioned.
6. State the
i.
Novelty of your research project (in 100 words):
ii.
Relevance of your research project to public health (in 100 words):
iii.
Relative importance of your research project in a given area (in 100 words):
iv.
Applicability of your research project in
(a) Short term:
(b) Long term:
5.

Present knowledge and relevant bibliography including full titles of articles

relating to the project.

6. Preliminary work already done by the Investigator(s) on this problem, e.g.

selection of subjects, standardization of methods, with results, if any.
7. Links with other DHR and ICMR projects (ad-hoc, task force or collaborative).
8. List of important publications of last 5 years of the all the investigators in the
relevant fields (enclose reprints, if available).
9. Detailed research plan. (give here the design of study, indicating the total number of
cases/samples/animals to be studied, the mode of selection of subjects specially
in experiments involving human beings, equipments and other materials to be used,
methodology/techniques to be employed for evaluating the results including
statistical methods any potential to obtain patents etc.)
10. Facilities in terms of equipment, etc, available at the sponsoring institution for the
proposed investigation.
11. Budget requirements (with detailed break-up and full justification): (i)
Staff
(ii)
Contingencies
Recurring
Non-recurring
(equipment)
Travel
(iii) Overhead charges

Section-C
BIODATA OF THE INVESTIGATORS(S)
1.
2.
3.
4.
5.

Name (Dr./Kum./Smt./Shri) First name(s)

Surname
Designation:
Complete Postal Address, Telephone Number, Fax, e-mail etc.
Date of Birth:
Educational Qualification : Degrees obtained (Begin with Bachelors Degree)
Degree

Institution

Field(s)
Year

6. Research/Training Experience
Duration

Institution

Particulars of work done

7. Research specialization (Major scientific fields of interest)

8. Important recent publications (last 5 years, with titles and References),
including papers In press
9. *Financial support
received
1. F rom DH R
i. in pas t
ii. *pres ent
iii. *P ending
2. From ICMR
i. Past
ii. *Present
iii. *Pending
3. From other sources
i. Past
ii. *Present
iii. *Pending
* This information must be given, otherwise the application will be returned. In
case no financial assistance has been received, nil should be stated. Indicate titles
of the projects and reference number, if available, for DHR/ ICMR grants.

Guidelines for Operation of Projects for Grantees of Research Projects

under Grant-in-Aid (GIA) Scheme of Department of Health Research
The vision of the Department of Health Research (DHR) is to bring modern health
technology to the people through innovations related to diagnostic, treatment methods and
vaccines for prevention; to translate them into products and processes and , in synergy with
concerned organizations, introduce these innovations into public health service. Under
Grant-in-Aid scheme for Inter-Sectoral Convergence and Coordination for promotion and
Guidance on Health Research, the Department of Health Research provides financial
assistance in the form of Grant-in-Aid for carrying out research studies to identify the
existing knowledge gap and to translate the existing health leads into deliverable products.
The financial assistance is provided by way of grants to scientists in regular employment
in the Universities, medical colleges, postgraduate institutions, recognized research and
development laboratories and NGOs (Applications from non-governmental agencies
should provide documentary evidence of registration, DISR Certificate, track record etc.).
1. Proposals in fundamental/ strategic research; development and evaluation of a tool,
and operational research are considered for DHR support.
2.

Research grants from the DHR are essentially intended to supplement the research
facilities available with the host institutions. All facilities for the conduct of research, such
as basic equipment and ordinary laboratory chemicals, glassware, furniture and other
assistance as may be required for the smooth working of the project shall be provided by
the Institute.

3. Who Can Apply?

a) Govt. Medical Institutions / Colleges / Universities
b) Private Institution/NGO (Registered with the Department of Scientific and Industrial
Research (DSIR), Govt. of India)/ recognized by DHR as a health research institute
c) Individual Scientists in regular employment in the Universities, medical colleges,
postgraduate institutions, recognized research and development laboratories and NGOs.
d) Professional bodies and scientific societies and associations
4. Projects Eligible for Funding:
(i) Research studies with emphasis on public health: Research studies on disease burden, risk
factors, diagnosis & treatment, etc of major diseases. Studies will be limited to Noncommunicable diseases only.
(ii) Translational Research Projects: Projects to translate the already identified leads into
products and processes in the area of human healthcare, through coordination among the
agencies involved in basic, clinical and operational research for use in the public health
system. This will comprise 75 leads already available with ICMR, 25 leads from
8

Extramural projects funded by ICMR and 15 leads from other Science & Technology
Departments/Organisations.
(iii) Inter-sectoral co-ordination including funding of Joint Projects: To promote
joint/collaborative research projects with other agencies involved in bio-medical/health
research in the country for optimum use of resources and transfer of knowledge.
(iv) Cost effectiveness analysis of health technologies through a health technology
assessment system: Development of guidelines for protocols/devices on cost effective
but viable technology/process/diagnostics for managing various diseases, to facilitate
public choice and controlling health care costs, while maximizing health outcomes.
5. Procedure for Receipt and Sanctioning of Proposals:
i. Proposals received in response to specific advertisement as also open ended applications
will be evaluated by an Expert Committee constituted by the Secretary, DHR consisting of
eminent scientists and subject specialists to assess the merit of the proposal.
ii. The funds will be released to the Head of the institute/organization and will be kept in a
separate bank account. The funds will be released in installments biannually. The first
installment will be sanctioned along with the approval letter. It would include the entire
grant for purchase of equipment, and recurring grant for six months.
iii. The 2nd installment of the year would be released based on the submission of the
Utilization Certificate (UC), along with the item-wise statement of expenditure, for at least
70% of the previously released grant, duly certified by the designated Accounts Officer of
the Host Institute and the Principle Investigator.
iv. Steps to procure the approved equipment should be initiated immediately (to avoid
escalation of cost) following the prescribed norms of the host institution.
v. Equipment procured through the DHR grant should bear a label "DHR funded". On
completion of the study a list of all equipments procured from the project funds along with
their cost, date of purchase, and suggestions for disposal should be sent to the DHR for
decision.
vi. Wherever applicable, an appropriate MOU with the institute/NGO/Applicant will be
signed to ensure that the interest of the DHR and public interest is protected.
vii. Once a project is approved for funding, DHR/ICMR would inform the Principal
Investigator (PI) the decision that the project has been technically approved for funding and
communicate the budget including the details of the staff, equipment(s), contingencies,
travel etc.
viii. The PI would inform the DHR/ICMR about the following:
a. His/Her acceptance of the budget and other terms and conditions.
b. For all equipment approved in the project, the PI is required to give a certificate from the
Head of the Institute to the effect that equipment is not available/accessible/cannot be spared
for this project work.
c. The name of the statutory auditor of the Medical College/Institute.
9

d. An undertaking that the staff engaged for the project would be the responsibility of the host
Institution and would have no claim to a permanent employment with the DHR/ICMR. They
are not to be treated as employees of the DHR/ICMR as they will be engaged only on
contract basis. They would be subject to administrative control and other rules & regulations
as applicable to them, of the Institute where the project is based.
ix. The budget for each project will be available under the following heads:
i.
ii.
iii.

Staff (Manpower)
Equipment
Consumables

iv.

Travel

v.

Contingencies/Miscellaneous

6. Date of Start :
The sanction letter would specify the date of start. It can only be a prospective date. If
however no date is mentioned in the sanction letter, the project would deemed to have
become operative on the day the grant is received by the Investigator. This date would
have to be communicated by the host Institute to the DHR/ICMR It will in no case be
later than one month after the receipt of the draft by the Institute. The date of start of a
project can be changed on the request of the PI provided no expenditure has been
incurred from the grant released by the Council.
7. Staff Component for the Projects:
(1)
The following categories of staff would be eligible to be engaged in the projects under
the scheme on fixed consolidated remuneration and contractual basis:
i. Research Scientists
ii. Research Associates
iii. Sr. Research Fellows
iv. Jr. Research Fellows
(2)
(3)

v. Technical and Field staff

The rates of remuneration for the aforesaid staff would be reckoned with reference to the
rates as applicable at the ICMR/DST for project staff.
Staff would be engaged initially for a period of one year and extendable till the duration
of the project. The staff engaged in the project will not have any claim, whatsoever, for
continuation of services in DHR/ICMR after completion/termination of the project.
10

(4)
(5)

Only those candidates can be engaged as Junior Research Fellows who have cleared the
ICMR-PGI,UGC-CSIR, DBT National Eligibility Test, or equivalent .
The progress of JRF and SRF working on a project will be assessed every year by a
committee consisting of PI, Head of Department (where PI is HOD, the next senior of
Department/Dean will be a member) and an external member who is an expert in the
relevant field - not less than an Associate Professor/Professor.

8. Up-Gradation/Down-Gradation of Approved Staff:

No alteration in the staff approved can be made by the institute/research Organisation
without the permission of DHR/ICMR.
9. Utilization of Travel Grant:
The grant can be utilized for travel within the country by the PI, co-investigator or of
Research staff working on the scheme:
a.
Attending seminars/symposia/conferences within the country provided the PI himself or
the project staff is presenting a research paper (based on the project work) which has
been accepted. Copy of the acceptance letter should be sent to the ICMR.
b.
Taking up field work/travel connected with the research work (TA/DA would be as per
the entitlement) including procurement of chemicals, equipments etc.
c.
Visiting the DHR/ICMR office for meetings related to the project
d.
Attending a training course related to the project, mainly for project staff e. The travel
grant cannot be used for foreign travel or any other expenses for visits abroad
10. Utilization of Contingent Grant :
This is meant for recurring as well as non-recurring expenditure. The contingent grant
can be utilized for purposes like, but not limited to:
a.
Acquisition of books and documents of relevance to the research topic in case these are
not available in the library, these would become the property of the Institution library and
after purchase and accession may be issued to the Department/ Scientist till they are
needed.
b.
Charges for specialized investigations for which facilities do not exist in the host institute
c.
Publication charges/ reprints/ off-prints of research papers published as an outcome of the
research
d.
Data entry charges
e.
Printing of questionnaire
f.
Computer utilities, charges for analysis of data (computer charges)
g.
Typing of research reports including preparation of the final report
h.
POL
i.
Communication charges

11

j.

The grant cannot be used for purchase of furniture items/office equipments such as
telephone, fax machine, computers etc.

(2 )

For contingency grant exceeding Rs.25,000/- per annum detailed breakup should be
given.

11. Equipment:
(1).
Provision for equipment(s) for conduct of the study shall be provided based on the
recommendations/approval of the project by the approval by the appropriate Expert
Committees. This would vary on the nature, scope and need of the project.
i. All equipments should be purchased according to the rules and procedures of the
Institutions where the project is to be carried out
ii. Equipment procured through the grant should bear a label "DHR/MOHFW funded"
iii. On completion of the study a list of all equipments procured from the project funds along
with their cost, date of purchase, and suggestions for disposal should be sent to the
Department.
iv. Equipments costing less than Rs 20,000 are generally allowed to be retained by the
Institute, while for those costing more than Rs 20,000 the Department would take
decision on case to case basis.
(2)
All expendable and non-expendable articles acquired for work of the project should be
purchased in accordance with the procedure in vogue in the host institutions. For
permanent and semi-permanent assets acquired solely or mainly out of the grant, a
separate record in the form of register in prescribed Performa (Asset Register) shall be
maintained by the Institute. The term "assets" means moveable property where the value
exceeds Rs.1000/-. Separate assets registers for items costing more than Rs.20,000/- and
less than Rs.20,000 may be maintained.
12. Overhead Expenses:
Overhead expenses, if any, may be met from miscellaneous expenses as per ICMR
norms.
13. Re-Appropriation of Funds:
Expenditure should on no account exceed the budget sanctioned for the project.
Expenditure incurred over and above the sanctioned amounts against one or more, subheads of expenditure such as pay & allowances, contingencies etc shall not be met
without the approval of the DHR, by re-appropriation of savings under remaining subheads (except under sub-head equipment) by re-appropriation of money during the
financial year, provided it is within over all sanctioned ceiling of the year. No
expenditure shall be incurred on items not sanctioned under the scheme. Savings should
also not be re-appropriated for meeting or incurring expenditure on staff that has not been
sanctioned by the Department.
12

14. Extension of the Project:

Extension beyond the approved duration would not be entertained. If
interesting/important leads emerge that need to be followed-up, a separate proposal may
be submitted. Only in exceptional cases, where a valid justification exists, and
recommended by the technical Evaluation Committee and Project Approval Committee
an extension can be considered to complete the project.
15. Change of Principal Investigator (PI)
PIs are encouraged to have a co-investigator in the project.
If for any reason the PI leaves the project, an eligible co-investigator could be considered
as the PI subject to recommendation of the PI, the Head of the Institution, and the
approval of DHR. Such a request should be sent well in advance.
In case the PI is shifting to any other Institution, the co-investigator could be made the
new PI, or the project could be transferred to the new Institution with the mutual
agreement of both Institutions and the approval of the DHR
The host Institution has an important role to play in the above contract. The
Institute/Principal Investigator will have to inform the DHR of any changes, and in
consultation with DHR take steps to ensure successful completion of the project before
relieving the Principal Investigator.
16. Number of Projects with the PI :
Under normal conditions, a PI should not be implementing more than three research
projects at a given point in time. While submitting an application for a research project,
the PI should give in detail all the research projects (completed, on-going). Fresh research
proposals can be considered only when the on-going research proposals are about to
conclude.
17. Annual Progress Report:
a)
The Host Institute would be required to submit an annual progress report and also give
audited statement of expenditure by the Auditor of the research Organization/Institute etc.
However, the first progress report should be submitted at least three months prior to the
completion of the annual report so as to enable the evaluation and provide the grants
within the completion of one year from the starting date. The subsequent annual report
will be for the period of one year.
b)
The financial and physical progress of the project would be evaluated by the DHR with
technical support from ICMR.
c)
The progress report and expenditure statement in respect of the project shall be reviewed
at the time of release of subsequent grants.
13

d)

e)

The Principal Investigator (PI) may be asked to present the progress at the meeting of the
Committee, if considered necessary. The consolidated report of the work done to be
provided to Department for evaluation and monitoring of progress and statement of
expenditure.
The suggestion and views of the Committee and mid-course correction, if any, would be
conveyed to the PI from time to time for effective conduct of the project. This would be
binding on the PI.

18. Final Project Completion Report (PCR):

(1).
At the completion of the project, the final report should be sent in the prescribed format.
(2)
The report should be submitted not later than three months from the date of completion
of the project.
(3 )
The report should be submitted not later than three months from the date of completion of
the project. 10% grant would be withheld for release after receipt of the final report.
(4)
The review of any other new project sent by the same applicant for financial support from
the Department would depend upon the previous track record in terms of compliance of
submission of requisite statement of Accounts and annual / final reports in time
(5)
Ten copies of final report have to be submitted by the applicant along with the final
audited statement of Accounts.
(6)
Action taken on Project Completion Report (PCR) - The final report is reviewed by the
PRC. If the report is found satisfactory, an abstract on the work done is published in the
ICMR Bulletin. System of keeping PCR: A few copies are retained by the DHR and soft
copies would be retained for eventual uploading on the DHR website.
19. Audit :
The department would normally accept audited report from auditors as applicable to the
concerned institution. Statement of accounts audited by Chartered Accountants approved
by or registered with the CAG and /or Ministry of Health & Family Welfare would also
be accepted. The necessary registration number should be provided for record.
20. Annual Utilization Certificate:
i.
The release of grants-in-aid and the terms and conditions thereof including submission of
utilization certificates shall be subject to the provisions GFRs.
ii.
Each year a simple statement of accounts giving the funds received and expenditure
incurred by 31st March needs to be submitted for release of the first installment for the
next year duly signed by the Accounts Officer of the Institute.
iii.
Unspent balance would be adjusted in the first installment for the next year
iv.
An audited statement would be essential for release of the second installment of the
annual grant from second year onwards.

14

21.Final Settlement of the Accounts

(1)
The final settlement of the Accounts will be done only after the receipt of the following:
a.
Final audited statement of expenditure
b
Final utilization certificate
c
List of equipments procured from the project along with their cost, date of purchase, and
suggestions for disposal
(2)
The grant paid by the DHR shall be refunded by the institution as and when the
investigator discontinues a scheme midway or does not follow the detailed technical
programme as laid down and approved by the DHR. All raw data (in all forms) should be
made available/accessible to DHR if needed.
22. Publication of Results/Presentation of Papers:
The research papers and publications based on the results of the research project should
acknowledge assistance by the DHR. Copies/reprints of papers published should be sent
along with the progress/final report.
23. Intellectual Property Rights :
All new intellectual property viz., patents, designs etc. generated as part of the research
supported by the DHR under the Scheme would belong to the department and other
partners as per the Indian Council of Medical Research IPR policy, till any new policy is
formulated by Department of Health Research.
24. Conflict of Interest :
In order to maintain the objectivity in the conduct and reporting of research, it is
imperative that the investigators should not have any financial or other interests that
undermine scientific integrity while recording and reporting their data. Any research or
other links of the investigators with industry are discouraged as such a link would
compromise or likely to compromise unbiased reporting of research data. In addition,
such a financial conflict of interest could lead to loss of public faith on the credibility of
data being reported, especially in the light of recent reports of financial conflict of
interest of investigators in drug and other clinical trials. All investigators, desirous of
DHR support should declare financial conflict of interest, if any, before submitting the
project for support. They should also ensure that during the conduct of the project, they
would also observe the same code of conduct. If the Department comes to know of any
unethical conduct on the part of investigator including improper/incomplete declaration,
the project is liable to be terminated immediately.

15

Annexure-1
Research studies areas to be taken-up under Grant-in-aid scheme of DHR
1. Research studies with emphasis on public health
S.N0.

Priority

Area

of Topic of the study

16

Research
1.1

1.2

1.3

1.4

1.5

1.6

1.7

1.8

Cancer

1.1.1
1.1.2
1.1.3
1.1.4

Estimation of State/region wise disease burden

Profiles of cancers
Risk factors identification
Development and evaluation of algorithms for
diagnosis and Management
1.1.5 Other areas relevant to the programme.
Mental Health
1.2.1 Epidemiological studies for assessing for disease
burden and determinants etc.
1.2.2 Development of skills for end of life care
1.2.3 Model projects under Brain Grid with NKN
1.2.4 Development and evaluation of algorithms for
diagnosis and management
1.2.5 Other areas relevant to programmes.
Cardiovascular
1.3.1 Epidemiological studies for Burden estimation
Diseases
(regional/states)
1.3.2 Socio-behavioral, lifestyle and other risk factors
1.3.3 Profile of CVS diseases
1.3.4 Development and evaluation of algorithms for
diagnosis and management
1.3.5 Other areas relevant to programmes.
Environmental Health/ 1.4.1 Burden estimation
occupational health
1.4.2 Impact of legislation
1.4.3 Air and water pollution
1.4.4 Health problems related to pesticides etc
1.4.5 Profile of occupational health problems of national
importance
1.4.6 Other areas relevant to programmes.
Stroke and neurological 1.5.1 State and regional data
disorders
1.5.2 Type of strokes
1.5.3 Risk factors estimations
1.5.4 Development and evaluation of algorithms for
diagnosis and management
1.5.5 Other areas relevant to programmes.
Diabetes
1.6.1 State and regional data
1.6.2 Risk factors estimations
1.6.3 Strategies for management at various levels
1.6.4 Other areas relevant to programmes.
Metabolic disorders
1.7.1 State and regional data along with risk factors
1.7.2 Development and evaluation of algorithms for
diagnosis and management
1.7.3 Other areas relevant to programmes.
Congenital
1.8.1 State and regional data including classification
Malformations
and 1.8.2 Risk factors estimations
Genetics
1.8.3 Development and evaluation of algorithms for
17

1.8.4
1.9

1.10

1.11

1.12

1.13

Kidney
disorders

and

liver 1.9.1
1.9.2
1.9.3
1.9.4
1.10.1
1.10.2
1.10.3
1.10.4
1.10.5

diagnosis and management

Other areas relevant to programmes
State and regional data and types
Risk factors estimations
Development and evaluation of algorithms for
diagnosis and management
Other areas relevant to programmes.
Studies on various aspects such as:
Vulnerability to diseases
Socio-cultural factors
Education and access to information
Gender specific public health interventions

Physical
Health
problems specifically
related
to
women
regarding
top
5
problems:
Heart diseases,
Breast
cancer/cervix
Osteoporosis
Depression
Autoimmune
diseases
Maternal health
1.11.1 Estimating morbidity and mortality patterns
1.11.2 Nutritional disorders
1.11.3 Tools for reducing MMR
1.11.4 Reproductive health
1.11.5 Health care seeking behavior
1.11.6 Other areas relevant to programmes.
Child health
1.12.1 Estimating morbidity and mortality patterns
1.12.2 Nutritional disorders (malnutrition and obesity)
1.12.3 Diarrhoeal and respiratory disorders
1.12.4 Factors affecting pre-term, LBW
1.12.5 Immunization
1.12.6 Other areas relevant to programmes.
Low child sex ratio and 1.13.1 Factors influencing female feticide
other
Gender
and 1.13.2 Social beliefs
Health
1.13.3 Qualitative research studies
1.13.4 Domestic violence
1.13.5 Other areas relevant to programmes.

18

2. Translational Research Projects

Item
2.1 Leads identified by
ICMR Institutes and partly
developed

Topic of the Study

The technologies targeted for 2013-14 include :
(i) diagnostic assays/ reagents/ devices for diabetes
mellitus; cervical cancer; thallesemia ; infectious
diseases such as tuberculosis, leptospirosis,
hepatitis E, rotavirus diarrhoea, food borne
pathogens, Chlamydia infections, kala- azar,
malaria, filarial and lung fluke;
(ii) vaccines for Japanese encephalitis, hepatitis E, ;
(iii)

nutrition: assays for bioavailability of iron ,

vitamin A estimation;

(iv)

Others: cooling garment to prevent and manage

heat effects; ergonomically designed rickshaw; test
for determination of viability of sperms; molecules,
metabolites / organisms for biological control of
mosquitoes.

31-75 : Leads identified as second priority likely to take 3-4

years to develop prototype/ technologies
2.2 Leads identified from
extramural projects
2.3 Leads identified by other
agencies/ requiring interdepartmental collaboration
with like DST, DBT, DSIR,
DRDO etc.

19

3. Inter-sectoral Co-ordination including funding of joint projects

S.N0.
Purpose of study
Joint projects with DBT /DST/DRDO on diagnostics & vaccine
3.1
3.1.1 Diagnostics in area of Cancer, Stroke, Diabetes, Vector borne diseases,
Tuberculosis, Leishmaniasis etc.
3.1.2 Vaccines for Vector borne diseases, Leishmaniasis etc.
3.1.3 Basic biology, polymers, devices, bio-instrumentation and other life science
related areas like nanotechnology etc.
Joint projects with DBT /DST/CSIR/ on New drug discovery
3.2
3.2.1 Drug discovery in the areas of Cancer, Stroke, Diabetes, Vector borne
diseases, Tuberculosis, Leishmaniasis etc.
3.2.2 Diagnostics, devices and therapeutics with DST, DBT, CSIR, DRDO,
Information Technology
Joint projects with AYUSH New drug discovery / Treatment
3.3
3.3.1 Drug discovery / new treatment in the areas of Cancer, Stroke, Diabetes,
Vector borne diseases, Tuberculosis, Leishmaniasis, cardiovascular diseases,
Mental disorders, arthritis, skin disorders etc.
3.3.2 Role of Yoga in cardio-vascular diseases, diabetes, stroke and neurological
disorders etc.Other alternate therapies
Joint projects with Department of Environment
3.4
3.4.1 Effect of climate change on vector borne diseases, and other communicable
diseases and impact of transgenic/ recombinant technology on health
3.4.2 Indoor and outdoor air pollution
3.4.3 Noise heat, radiation pollution etc
3.4.4 Pollution due to chemicals, pesticides, other toxic waste etc.
3.4.5 Development of disaster management tools

Joint projects with DARE/ ICAR

3.5
3.5.1 Diagnostics, treatment and control of diseases on Zoonosis
3.5.2 Improvement of nutritional status Nutritional safety use of pesticides; other
toxic contaminants etc
Joint projects with Department of Space
3.6
3.6.1 GIS mapping of Vector borne diseases with geo-climatic factors
3.6.2 GIS mapping of cardio-vascular, cancer, diabetes diseases with population
density, industry, agricultural produce etc.
Joint projects with M/o of Women & Child Development, Department of Health & FW
and ICSSR/ Department of information technology/ labour etc.

20

3.7

3.7.1
3.7.2
3.7.3
3.7.4
3.7.5
3.7.6
3.7.7
3.7.8
3.7.9

Nutritional patterns and developing interventions with WCD, Nutritional

institutes
Socio-behavioural factors related with maternal health with ICSSR
Health education with WCD
Public health interventions with Department of Health and women and child
development, social justice
Under-five morbidity pattern with ICDS
Nutritional interventions with schools, WCD
Studies with ICSSR on Low Child sex ratio, female feticide, domestic
violence and sexual violence at work place
Model projects on implementation of Knowledge management policy;
Other model projects related to national programmes including health
systems research and socio-behavioural interventions

21

4. Cost effectiveness analysis of health technologies through a health technology assessment

system
S.N0. Area of
Sub-areas
Research
4.1

4.2
4.3

4.4

4.5

4.6

4.7

4.8
4.9
4.10

Topics of the study

Cancer

4.1.1 Methods for effective and early diagnosis

4.1.2 Impact of health services for cancer management
4.1.3 Efficacy of different regimens
4.1.4 Development of guidelines for diagnosis and management
Mental Health
4.2.1 Scales and tools for assessment of Mental Health
4.2.2 Evaluation of newer modalities of treatment like ECT etc
4.2.3 Development of guidelines for diagnosis and management
Cardiovascular Diseases
4.3.1 Assessment of promotive models for prevention of risk
factors
4.3.2 Efficacy of newer diagnostic tests
4.3.3 Models of early treatment to reduce mortalities
4.3.4 Health informatics and health technology assessments
4.3.5 Development of guidelines for diagnosis and management
Stroke and neurological disorders
4.4.1 Newer diagnostics
4.4.2 Newer treatment modalities
4.4.3 Preventive models
4.4.4 Development of guidelines for diagnosis and management
Diabetes
4.5.1 Newer diagnostics
4.5.2 Newer management strategies
4.5.3 Health promotive and preventive models
4.5.4 Development of guidelines for diagnosis and management
Malaria
4.6.1 Efficacy of alternate drugs
Dengue
4.6.2 Newer vaccines
Chikungunya
4.6.3 Newer drugs including larvicidals
Japanese Encephalitis (Vector Borne 4.6.4Preventive technologies
Diseases)
4.6.5 Use of technologies for prevention and cure
4.6.6 Development of guidelines for diagnosis and management
Tuberculosis / Leprosy
4.7.1 Multidrug resistance
Other Mycobacterial diseases
4.7.2 Newer diagnostics
4.7.3 Newer drugs and combinations
4.7.4 Development of guidelines for diagnosis and management
Leishmaniasis / Kalazar
4.8.1 Newer diagnostics
4.8.2 Newer drugs
Zoonoses
4.9.1 Newer diagnostics
4.9.2 Newer drugs
Guidelines for
management of
important maternal and child health
problems; region specific guidelines
for nutrition; enteric infections, acute
fevers; PUO; genetic disorders,
blood disorders etc;

22

Annexure 2
Cost details of permanent equipment/assets
(Please use a separate sheet for each equipment)
1.
2.
3.
4.
5.

Name of equipment/ asset with model, name etc. and date of procurement
Sanctioned amount:
Actual expenditure (this should include only the cost of equipment, insurance, freight
charges and octroi etc.)
Other expenses, if any (expenses such Bank charges, agency commission etc.,
should be avoided through appropriate negotiations. If unavoidable expenses
incurred, the same may be indicated
Utilization rate (%)

23

13

Annexure-3

FORMAT FOR ANNUAL PROGRESS REPORT

Proposal ID:

Date :

1.

Project title

2.

PI (name & address)

3.

Co-PI (name & address)

4.

Date of start

5.

Duration

6.

Objectives of the proposal

7.

Methodology

8.

Interim modification of objectives/methodology (with justifications)

9.

Summary on progress (during the period of report)

10.

Applied value of the project

11.

Research work which remains to be done under the project

12.

Any publications.

13.

Any patents applied for

14.

If additional budget or staff is required for the remaining part of

the research work, please give justifications and details.

Signature
Designation

13

14

Annexure-4

Format for Annual Statement of Accounts to accompany request for release of First
Installment
(Year means Financial Year i.e. 1st April to 31st March of next year)
1.

3.

:.......................

Total Project Cost

:
Rs
Sanction /Revised Project cost(if applicable) :Rs.......................

4.

Date of Commencement of Project

5.

Statement of Expenditure

2.

Sanction letter No.

S.No. Sanctioned/Heads

1.
2.
3.
4.
5.
6.
7.
8.

Salaries
Permanent
Equipments
Supplies &
Materials
Travel
Contingencies
Overhead
Others (if any)
Total

:
.......................
:.
......................

Funds
Expenditure
Balance Requirement Remarks
of Funds upto
Allocated Incurred
as on
st
31 March
I
II
III
(Date)
Year Year Year

Signature of Principal Investigator

Officer with date

Signature of Accounts
With date

14

Annexure-5
Check list for covering note to accompany Utilization Certificate of grant for the
project for the period ending 31st March, 20 __)
1) Title of the project
2) Name of the Institutions
3) Principal Investigator
4) DHR letter No. and date sanctioning the project.
5) Head of account as given in the original sanction letter
6) Amount received during the financial year (Please give No. & Date of DHR's
sanction letter for the amount)
7) Total amount that was available for expenditure (excluding commitments)
during the financial year (SI.No.6+7)
8) Actual expenditure (excluding commitments) incurred during the financial year
(upto 31st March).
9) Balance amount available at the end of the financial year.
10) Amount already committed, if any.
11) Amount to be carried forward to the next financial year (if applicable). Indicate
the amount already committed with supporting documents.

15

Annexure 6
FORMAT FOR UTILISATION
CERTIFICATE
(ANNUAL/FINAL)
Proposal ID:

Certified that out of Rs .................... of grants-in-aid sanctioned during the year............

in favour of ............................. under DHR Letter No........................... and Rs
................................on account of unspent balance of the previous year, a sum of Rs ................. has
been utilized for the purpose of ........................... for which it was sanctioned and that
the balance of Rs. ............. remaining unutilised at the end of the year has been surrendered to
DHR /ICMR(vide cheque No ........................... Dated............/will be adjusted towards the grants-in-aid
payable during the next year i.e ............................................

Signature of
Principal Investigator
with date

Signature of Registrar/
of the Institute with date

Signature of Accounts
of the Institute with date

16

FORMAT FOR FINAL REPORT

Annexure-7

Proposal ID:
1. Title of the Project:
2. Principal Investigator and Co-Investigators
3. Implementing Institution and other collaborating Institutions
4. Date of commencement
5. Duration
6. Date of completion
7. Objectives as approved
8. Deviation made from original objectives if any, while implementing the project and
reasons thereof.
9. Experimental work giving full details of experimental set up, methods
adopted, data collected supported by necessary tables, charts, diagrams and
photographs.
10. Detailed analysis of results indicating contributions made towards increasing the
state of knowledge in the subject.
11. Conclusions summarizing the achievements and indication of scope for future work.
12. S&T benefits accrued:
I. List of research publications with complete
details: Authors, Title of paper, Name of
Journal, Vol., page, year
II

Manpower trained on the project:

a.
Research Scientists or Research Fellows
b.
No. of PhDs produced
c.
Other Technical Personnel trained

III. Patents taken, if any:

IV Products developed, if any.
13. Abstract (300 words for possible publication in DHR/ ICMR Bulletin).

14. Procurement/usage of
17

Equipment a.
S.No Name of
.
Equipment

Make/M Cost
odel
FE/Rs

Date of
Installation

Utilisation Remarks regarding

rate %
maintenance/breakdown

b.
Suggestions for disposal of
equipment(s)

Name and signature with

date
1.
(Principal Investigator)
2.
(Co-Investigator)

18

Annexure 8
FORMAT FOR FINAL STATEMENT OF EXPENDITURE
(to accompany the Final Report)
1) Sanction letter No.
2) Total project cost
(Sanctioned/revised project cost, if applicable)
3) Date of commencement of project:
4) Date of completion of project:
5) Grant revised in each year (financial):
S.
No.

Sanctioned
Heads

1
1
2
3
4
5
6

2
Salaries
Equipment
Consumables
Travel
Contingencies
Overhead
Expenses
Others
(if any)
Total

7
8

Funds
Expenditure Incurred
Balance Remarks
Allocated Financial year-wise
(if any)
st
nd
rd
th
I yr II yr III yr IV yr Tota
l
3
4
5
6
7
9
10
8

Amount to be refunded/reimbursed (whichever is appropriate): Rs.

Name & Signature

Principal Investigator
With date

Signature of Competent
Financial/audit
authority With date